de Borst Martin H, Diks Sander H, Bolbrinker Juliane, Schellings Mark W, van Dalen Mario B A, Peppelenbosch Maikel P, Kreutz Reinhold, Pinto Yigal M, Navis Gerjan, van Goor Harry
Dept. of Pathology, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands.
Am J Physiol Renal Physiol. 2007 Jul;293(1):F428-37. doi: 10.1152/ajprenal.00367.2006. Epub 2007 Apr 11.
Regulation of protein kinase activities is crucial in both physiology and disease, but analysis is hampered by the multitude and complexity of kinase networks. We used novel peptide array chips containing 1,152 known kinase substrate sequences to profile different kinase activities in renal lysates from homozygous Ren2 rats, a model characterized by hypertension and angiotensin II (ANG II)-mediated renal fibrosis, compared with Sprague-Dawley (SD) control rats and Ren2 rats treated with an angiotensin-converting enzyme inhibitor (ACEi). Five-wk-old homozygous Ren2 rats were left untreated or treated with the ACEi ramipril (1 mg.kg(-1).day(-1)) for 4 wk; age-matched SD rats served as controls (n = 5 each). Peptide array chips were incubated with renal cortical lysates in the presence of radioactively labeled ATP. Radioactivity incorporated into the substrate motifs was measured to quantify kinase activity. A number of kinases with modulated activities, which might contribute to renal damage, were validated by Western blotting, immunoprecipitation, and immunohistochemistry. Relevant kinases identified by the peptide array and confirmed using conventional techniques included p38 MAP kinase and PDGF receptor-beta, which were increased in Ren2 and reversed by ACEi. Furthermore, insulin receptor signaling was reduced in Ren2 compared with control rats, and G protein-coupled receptor kinase (GRK) activity decreased in Ren2 + ACEi compared with untreated Ren2 rats. Array-based profiling of tissue kinase activities in ANG II-mediated renal damage provides a powerful tool for identification of relevant kinase pathways in vivo and may lead to novel strategies for therapy.
蛋白激酶活性的调节在生理和疾病过程中都至关重要,但激酶网络的多样性和复杂性阻碍了相关分析。我们使用了包含1152个已知激酶底物序列的新型肽阵列芯片,来分析纯合Ren2大鼠肾裂解物中的不同激酶活性。Ren2大鼠是一种以高血压和血管紧张素II(ANG II)介导的肾纤维化为特征的模型,我们将其与Sprague-Dawley(SD)对照大鼠以及用血管紧张素转换酶抑制剂(ACEi)治疗的Ren2大鼠进行了比较。5周龄的纯合Ren2大鼠不进行治疗或用ACEi雷米普利(1 mg·kg⁻¹·d⁻¹)治疗4周;年龄匹配的SD大鼠作为对照(每组n = 5)。将肽阵列芯片与肾皮质裂解物在放射性标记的ATP存在下孵育。测量掺入底物基序中的放射性以量化激酶活性。通过蛋白质印迹、免疫沉淀和免疫组织化学验证了许多活性受到调节的激酶,它们可能导致肾损伤。通过肽阵列鉴定并使用传统技术确认的相关激酶包括p38 MAP激酶和血小板衍生生长因子受体-β,它们在Ren2大鼠中升高,而ACEi可使其逆转。此外,与对照大鼠相比,Ren2大鼠的胰岛素受体信号传导降低,与未治疗的Ren2大鼠相比,Ren2 + ACEi大鼠的G蛋白偶联受体激酶(GRK)活性降低。基于阵列的ANG II介导的肾损伤中组织激酶活性分析为体内相关激酶途径的鉴定提供了一个强大的工具,并可能导致新的治疗策略。